Anixa Biosciences (ANIX) Long-Term Investments (2010 - 2014)

Anixa Biosciences (ANIX) has 5 years of Long-Term Investments data on file, last reported at $4.2 million in Q3 2014.

• Quarterly Long-Term Investments fell 2.77% year-over-year to $4.2 million in Q3 2014, while the trailing twelve-month figure through Jul 2014 was $4.2 million (down 2.77% YoY) and the FY2013 annual result came in at $4.2 million, down 11.23% from the prior year.
• Long-Term Investments rose to $4.2 million in Q3 2014, from $4.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $7.1 million in Q3 2011 to a low of $127500.0 in Q4 2010.
• A 5-year average of $3.6 million and a median of $4.2 million in 2013 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2012 — Long-Term Investments tumbled 98.21% — and 2013, when it jumped 4622.18%.
• Tracing ANIX's Long-Term Investments over 5 years: stood at $127500.0 in 2010, then surged by 4121.22% to $5.4 million in 2011, then retreated by 12.15% to $4.7 million in 2012, then retreated by 11.23% to $4.2 million in 2013, then declined by 1.1% to $4.2 million in 2014.
• The last three Long-Term Investments figures came in at $4.2 million (Q3 2014), $4.0 million (Q2 2014), and $4.0 million (Q1 2014), per Business Quant data.